The administration of echocardiographic contrast agents has been shown to improve accuracy and be cost-effective in patients with suboptimal endocardial definition. We sought to investigate the implementation of contrast agents in clinical practice.
Introduction
Between 10 and 15% of patients undergoing standard transthoracic echocardiography have suboptimal left ventricular endocardial definition. 1, 2 In patients referred for stress echocardiography a higher proportion (up to 25%) may have two or more poorly visualized segments. 3 Furthermore, in those with suboptimal images, a large proportion of myocardial segments are not visualized well. 1 This can lead to an inaccurate quantification and assessment of left ventricular function. An accurate assessment of the LV ejection fraction is critical in the management of multiple pathologies. In patients with heart failure, eligibility for treatment with cardiac resynchronization therapy and prophylactic implantable cardiac defibrillators is based on an ejection fraction of ,35%. 4, 5 Chemotherapy regimens are known to be cytotoxic with a potential to cause left ventricular impairment. Cessation of these agents is recommended if the ejection fraction during treatments falls by .10%. 6 The use of echocardiographic contrast agents has been shown to enhance the visualization of left ventricular wall segments, improve the quantification of the LV ejection fraction, reduce inter-observer variability, and be more cost-effective as a result of less downstream investigations. 1, 7, 8 Recent guidelines recommend the use of echocardiographic contrast agents where two or more segments are not well visualized. 9, 10 Despite the evidence base and guideline recommendations for the use of contrast agents in routine echocardiographic practice, there are no data identifying the implementation of guidelines into clinical practice.
Methods

Identification of echocardiography departments within the UK
A database of all United Kingdom National Health Service (NHS) Trusts was created from the NHS website (www.nhs.uk). Each NHS trust may be composed of several hospitals. Therefore each trust was contacted by telephone to establish which of its constituent hospitals had an echocardiography department. The clinical head of the echocardiography department in each hospital was identified and the contact e-mail address was obtained.
Questionnaire design
A questionnaire was designed to identify the prevailing practice of contrast echocardiography use within the UK. Thirty-two questions were formulated to identify data in four core areas.
Core areas and data acquired 
Questionnaire mailing
The questionnaire was placed into an electronic template using commercial online software. The questionnaire was e-mailed to the head of echocardiography at each designated hospital. Non-respondents to the initial e-mail were sent a reminder at weekly intervals.
Statistics
Data are reported as a median and inter-quartile range or number and percentage. Multiple logistic regression analysis was used to identify predictors of the use of echocardiographic contrast agents. All tests of significance were two sided. A probability value (P) of ,0.05 was considered significant. Statistical analysis was performed using StatsDirect Version 2.5.7 (StatsDirect, UK).
Results
A total of 198 acute NHS hospitals with echocardiography departments were identified. One hundred and ten (55.6%) of echocardiography departments responded. Of these, three questionnaires were not fully completed and therefore excluded. Therefore data from 107 (54%) departments were used for the final analysis. From this cohort, 30 departments (28%) were tertiary centres, and 77 (72%) were district general hospitals.
Contrast use
The total number of echocardiograms performed per year was 673,121 (median of 6000 per department, inter-quartile range 4500-10 000). Of these 25,834 (3.8%) were performed with contrast (median 100 per department, inter-quartile range 20 -400). Seventy-four departments performed stress echocardiograms. A total of 32,167 stress echocardiograms were performed (median 255 per department, inter-quartile range 30 -500). Of these 21,417 (66.6%) were performed with contrast (median 76 per departments, inter-quartile range 43 -100).
Facilities
The total number of echocardiography machines operated by the 107 departments is 551 (median 5 and inter-quartile range 3-6). Of these 358 (65%) machines (median 3 per department) had software allowing contrast settings ( Barriers to the introduction of contrast into the echocardiography laboratory
The most common reason cited for difficulties in the introduction of contrast agents into routine echocardiographic was staff training in 37 departments (34.6%), extra time required for contrast study in 32 departments (29.9%), expense of contrast in 20 departments (18.7%), safety of contrast agents in 9 departments (8.4%), and the lack of suitable echocardiographic machines in 9 departments (8.4%).
Predictors of contrast agent use
A logistic regression analysis was performed to identify predictors of the use of contrast agents within an echocardiography department. The type of hospital (tertiary or district general), ≥5 echocardiography machines, ≥6 sonographers, the presence of sonographers who could perform i.v. cannulation, the presence of sonographers who could administer contrast, time duration of a study ≥30 min, the presence of a physician throughout the duration of the working day, the presence of a consultant cardiologist with subspeciality training in echocardiography, and the presence of a stress echocardiography service were entered in to the logistic regression model. 
Discussion
This is the first study to examine the integration of contrast echocardiography into routine clinical practice within a large cohort of echocardiographic departments. Several previous studies have identified between 10 and 15% of routine echocardiograms having incomplete endocardial border visualization. 1, 2 In this study, only 3.8% of studies were undertaken with contrast enhancement. Thus, at least 60% of patients with suboptimal images did not receive contrast administration. Only one-third of echocardiography departments could administer contrast routinely in patients whose echo windows were suboptimal at the same visit.
Of concern is that 8.4% of departments do not administer contrast at all. These figures are disappointing given the wealth of evidence pointing to improved accuracy, cost effectiveness, and reduced requirement for further investigations associated with the use of contrast agents. 4, 7, 8 In contrast, more than two-thirds of stress echocardiograms were performed with the aid of contrast enhancement. Several barriers to the routine implementation of contrast use in echocardiography departments were identified by the survey. The administration of contrast requires a team approach to manage several processes and steps required to achieve the optimal benefit to patients. This requires obtaining consent from the patient, achieving i.v. access, administering the contrast, optimizing machine settings for contrast use, and interpretation of the study by the sonographer or physician.
Administration of contrast and staff training/supervision
The logistic regression model shows that the administration of contrast to .10% of studies was associated with the presence of at least one sonographer in the department who could perform i.v. cannulation. Overall, the proportion of sonographers who can perform i.v. cannulation (15.8%) and administer contrast agents (5.9%) were small. Within the UK there are no licensing or training schemes for sonographers who wish to perform i.v. cannulation or administer contrast, although local protocols may exist.
Logistic regression also showed the presence of a cardiologist with subspecialty training in echocardiography, the presence of a stress echocardiography service and the presence of a doctor throughout the working day were predictors of the use of contrast. Both in the UK and USA there is a wide variation in the supervision, training, and support provided to sonographers in echocardiography departments. Although a dedicated cardiologist with expertise in echocardiography may be present in academic centres, this may not be the case in smaller, non-academic centres. In this study, 29% of echocardiography departments did not have a cardiologist with subspecialty training in echocardiography. Another important consideration for contrast echocardiography is the administration of contrast, albeit very rare, may result in an allergic reaction and, therefore, requires a physician in attendance within the department. In this study, 36.4% of departments did not have a physician present during the working day to oversee contrast administration. Indeed, almost one-third of departments reported that the lack of staff trained in contrast echocardiography was a barrier to the use of contrast. This serves to highlight the need for specialist training, supervision and support of echocardiography departments by specialist medical staff to provide an optimal service which is unlikely to be provided by a general cardiologist.
Work-flow and facilities
The median time duration of a study was 30 min. Despite this, the duration of an echocardiogram was not a significant predictor of the use of contrast. This is potentially because almost half of departments provided extra time if contrast was needed. However, almost one-third of departments thought that the extra time required for a contrast enhanced study was a barrier towards the use of echocardiographic contrast agents. A possible explanation for the conflicting view maybe that departments which allow extra time for contrast enhanced studies may only use contrast in patients where image quality is almost uninterpretable. This very small volume of patients may not impede work-flow in the department. Time may be more of a constraint if departments adopted a more liberal and appropriate use of contrast in the 10-15% of patients in whom more than two segments are not visualized.
Reimbursement
Nearly one in five departments stated that the reason for limited contrast use was the expense of the contrast agent. In the UK, a provider does not get additional reimbursement for the use of contrast agents during echocardiography. Several studies have shown that the use of echocardiographic contrast agents reduces the number of un-interpretable studies with reduced referrals for other diagnostic tests. 1, 11, 12 Overall these studies showed that, despite the extra initial expense, contrast agents produced a net saving per patient.
Protocols and consent
This overview of UK practice suggests a protocol for the administration of echocardiographic contrast agents was in place in 51% of departments, 29% required patients to read an information sheet prior to the administration of contrast, and 23% required patients to sign a consent form agreeing to the use of contrast agents. In a retrospective review of adverse effects related to 66,164 administered doses of two contrast agents, Wei et al. 13 found adverse reactions to contrast in just 0.01% of cases. Multiple studies have confirmed contrast administration to be safe, although there is a very small risk of allergic reactions and minor adverse effects. 13 -15 Neither the American Society of Echocardiography or European Association of Echocardiography guidelines mandate signed patient consent to undergo contrast echocardiography. 9, 10 The Inter-societal accreditation commission standards for laboratory accreditation require a written policy for the use of contrast agents. 16 A protocol may be helpful for staff in order to reinforce the indications for contrast echocardiography, ensure the safe use of contrast agents and improve work-flow patterns for contrast studies within a department.
Stress echocardiography
This survey also identified almost 70% of stress echocardiograms that were performed with the use of contrast compared with only 3.8% of resting transthoracic studies. Furthermore, logistic regression demonstrated that departments performing stress echocardiography was a predictor of the use contrast during their routine transthoracic studies. The result is not surprising as, in the UK, a physician is almost always present during stress echocardiography and there is a high likelihood they will be a cardiologist with an interest in stress echocardiography. The nature of the investigation means there will almost always be an i.v. access line in situ and contrast is usually administered by sonographers in the presence of a physician. Finally, there are numerous stress echocardiography work shops where the use of contrast is encouraged even where resting windows are optimal because of the probability that image quality may deteriorate after stress.
Limitations
The data obtained for this study were in the form of an electronic survey. Not all echocardiography departments within the UK responded to the survey or fully completed the survey, although we believe that a sample size of 107 departments (54% of the total number of echocardiography departments within the UK) is approximately representative of current practice. It is possible departments who do not use contrast were less likely to respond to the survey and therefore are under-represented and therefore the overall nationwide use of contrast may be even lower than we report. The data were dependent on reliable information provided by heads of echocardiography departments and there was no other external verification of this information.
Summary
The use of ultrasound contrast agents within routine echocardiographic practice in the UK is limited with ,4% of studies performed with contrast enhancement. Major barriers to the implementation of contrast use are the absence of senior medical specialists in echocardiography directly supervising echocardiography departments, training, and accreditation of sonographers to independently administer contrast and perform i.v. cannulation and re-imbursement of contrast costs.
